| Income Statement | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-06-30 |
|---|---|---|---|---|
| (loss) income before provision for income taxes | -3,647,914 | -3,336,120 | -2,668,713 | 1,849,501 |
| Net loss from continuing operations | -3,647,914 | - | - | - |
| Net loss from discontinued operations, net of tax | -336,195 | - | - | - |
| Net (loss) income | -3,984,109 | -3,336,120 | -2,668,713 | 1,849,501 |
| Less net loss attributable to noncontrolling interest | -38,746 | -31,945 | -29,301 | -30,295 |
| Net (loss) income attributable to applied dna sciences, inc | -3,945,363 | -3,304,175 | -2,639,412 | 1,879,796 |
| Deemed dividend related to warrant modifications | 15,500,244 | 23,919,429 | 14,907,223 | - |
| Net (loss) income attributable to common stockholders | -19,445,607 | -27,223,604 | -17,546,635 | 1,879,796 |
| Earnings per share, basic | -34 | -15.35 | -0.56 | 0.47 |
| Earnings per share, diluted | -34 | -15.35 | -0.56 | 0.47 |
| Weighted average number of shares outstanding, basic | 572,018 | 1,773,086 | 31,518,861 | 4,014,261 |
| Weighted average number of shares outstanding, diluted | 572,018 | 1,773,086 | 31,518,861 | 4,014,261 |
APPLIED DNA SCIENCES INC (APDN)
APPLIED DNA SCIENCES INC (APDN)